Evotec (OTCMKTS:EVTCY) Reaches New 12-Month Low at $5.28

Evotec SE (OTCMKTS:EVTCYGet Free Report) shares hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $5.28 and last traded at $5.34, with a volume of 72926 shares. The stock had previously closed at $5.30.

Evotec Stock Down 4.1 %

The firm has a market capitalization of $1.69 billion, a PE ratio of 12.49 and a beta of 0.98. The company has a fifty day moving average price of $4.92 and a 200-day moving average price of $6.88. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57.

Evotec Company Profile

(Get Free Report)

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.

Recommended Stories

Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.